Chiesi USA
Manufacturing · North Carolina, United States · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
175 Regency Woods Pl Ste 600, Cary, Nort...Phone Number
(919) 678-6611Website
www.chiesiusa.comRevenue
$478 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
2
2
1
1
1
About Chiesi USA
Chiesi USA is dedicated to developing and commercializing pharmaceutical products that cater to the needs of healthcare providers and their patients. Their offerings aim to enhance the management of various medical conditions, ultimately improving patient outcomes. The company is actively involved in research and development to address unmet medical needs and participates in community engagement initiatives focused on healthcare access and environmental health. Chiesi USA emphasizes sustainability and recognizes the importance of its impact on patients, the planet, and the community.Explore more
Chiesi USA Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Chiesi USA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Chiesi USA
Chiesi USA, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Chiesi USA has new funding data
Click to see if Chiesi USA had a recent Job posting/layoffs
Product Launch: Get notified when Chiesi USA launches new products
Check if Chiesi USA has recently received funding, and reach out quickly before it becomes old news!
Check out if Chiesi USA is spiking on competitors!
Earning: See what the market has to say on Chiesi USA recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Chiesi USA as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Chiesi USA is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Chiesi USA is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Chiesi USA.
Chiesi USA financials insights
Gather financial insights about Chiesi USA, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2003
Series B
$56M
2004
Stock Offering
$42M
Chiesi USA Tech Stack
A closer look at the technologies used by Chiesi USA
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Person-Based
Medical Research
Hiring Plans
Chiesi USA has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Chiesi USA has more open roles in Sales than it has had at any time in the past 12 months with an increased focus that include Sales Territory Management.
Hiring Plans
Hiring Plans
Hiring Plans
Chiesi USA News & Media
Chiesi Announces FDA Acceptance of New Drug Application for its Triple Combination Inhaler for the Maintenance Treatment of Asthma
The U.S. FDA has accepted Chiesi's New Drug Application (NDA) for its investigational maintenance treatment of asthma in adults.Chiesi USA Releases 2023 Sustainability Report and Highlights US Community Engagement Strategy Focus Areas
CARY, N.C., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Chiesi (key-A-zee), an international research-focused biopharmaceutical group, announced the release of its 2023 Sustainability Report, available here, which showed the company in 2023 has maintained its aggressive approach to delivering shared value for its stakeholders around the globe. Additionally, Chiesi announced today that its US community engagement focus areas in the US will address patients’ access to care, environmental impacts, food insecChiesi to Present New Data Showcasing Depth of Respiratory Leadership at the American Thoracic Society 2024 International Conference
CARY, N.C., May 16, 2024 (GLOBE NEWSWIRE) -- Chiesi USA, Inc. (key-A-zee), the U.S. affiliate of Chiesi Farmaceutici, an international research-focused healthcare Group (Chiesi Group), today announced the presentation of eight abstracts from Chiesi’s global respiratory research portfolio at the American Thoracic Society (ATS) 2024 International Conference in San Diego from May 17-22, 2024. In addition, Chiesi will showcase its commitment to innovation through additional sponsorship opportunitiesChiesi USA Appoints Richard Smith as Vice President and Business Unit Leader, U.S. AIR
CARY, N.C., April 15, 2024 (GLOBE NEWSWIRE) -- Chiesi USA, Inc. (key-A-zee), the U.S. affiliate of Chiesi Farmaceutici, an international research-focused healthcare Group (Chiesi Group), today announced it has appointed Richard Smith as vice president and business unit leader of U.S. AIR. Smith will report to Jon Zwinski, CEO and general manager of Chiesi USA.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Chiesi USA
Sign Up For FreeTo access detailed company insights
Chiesi USA is dedicated to developing and commercializing pharmaceutical products that cater to the needs of healthcare providers and their patients. Their offerings aim to enhance the management of various medical conditions, ultimately improving patient outcomes. The company is actively involved in research and development to address unmet medica... Read More
